Osteosarcoma is the most common type of bone cancer, impacting between 400 and 600 children, adolescents and young adults per year in the United States. It has historically been a very complicated cancer to study, leaving many researchers and advocates bewildered and discouraged. However, in recent years there has been strong philanthropic and scientific investment […]
$75,000 funds The Sam Day Endowed Lectureship in Pediatric Oncology at Doernbecher Children’s Hospital!
The Sam Day Endowed Lectureship in Pediatric Oncology creates an opportunity for providers to learn about leading edge developments in research and the treatment of rare pediatric cancers from world class experts. Though topics will always be relevant to oncology, lectures will benefit a wide range of pediatric and young adult providers, and will stimulate […]
Researchers at the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute have made monumental progress in the treatment of childhood blood cancers with their groundbreaking CAR T-cell therapy. This is a method of removing a person’s T-cells (a type of white blood cell that is part of the immune system), and re-engineering […]
The Sam Day Foundation has partnered with the Spada Pediatric Sarcoma Foundation to fund an innovative program developed by the hard work of the Beat Childhood Cancer Consortium and North Carolina’s Atrium Health, and led by Dr. Giselle Sholler. The program is designed to offer a treatment plan for kids based on their tumor profile […]
Since 2019, Sam Day Foundation granted $320,000 to the Children’s Cancer Therapy Development Institute for an innovative and comprehensive tumor bank program.
The Sam Day Foundation has awarded $143,000 to Oregon Health Science and University’s Pediatric Sarcoma Researcher Dr. Monika Davare! The Davare Lab has been investigating an interesting small molecule which has demonstrated potential to become an effective targeted treatment for Ewing’s Sarcoma. Since existing treatments for Ewing’s Sarcoma consist of high dose chemotherapy, which is […]